miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer
Authors
Keywords
IDO1, miR-448, CD8, Colon cancer, Immunology, Tumor microenvironment
Journal
Journal for ImmunoTherapy of Cancer
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-07
DOI
10.1186/s40425-019-0691-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO
- (2018) Xinhong Pei et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer
- (2018) Soo Jung Lee et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
- (2018) Qian Huang et al. Journal of Hematology & Oncology
- Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
- (2018) Muhammad Umair Mushtaq et al. Journal for ImmunoTherapy of Cancer
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- MicroRNA-146a induces immune suppression and drug-resistant colorectal cancer cells
- (2017) Samaneh Khorrami et al. TUMOR BIOLOGY
- MicroRNA-105 is involved in TNF-α-related tumor microenvironment enhanced colorectal cancer progression
- (2017) Zetao Shen et al. Cell Death & Disease
- A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression
- (2017) Abhishek Mangaonkar et al. Scientific Reports
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis
- (2016) Xinru Zhou et al. Oncotarget
- miR-448 suppresses E2F3 to inhibit proliferation and induce apoptosis in human colorectal cancer cells
- (2016) Dongsheng Wang et al. Translational Cancer Research
- The role of plasma IDO activity as a diagnostic marker of patients with colorectal cancer
- (2014) M. Cavia-Saiz et al. MOLECULAR BIOLOGY REPORTS
- Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues
- (2014) I. Theate et al. Cancer Immunology Research
- IDO1 Metabolites Activate β-catenin Signaling to Promote Cancer Cell Proliferation and Colon Tumorigenesis in Mice
- (2013) Ameet I. Thaker et al. GASTROENTEROLOGY
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
- (2012) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Indoleamine 2,3 dioxygenase in intestinal disease
- (2012) Matthew A. Ciorba CURRENT OPINION IN GASTROENTEROLOGY
- Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
- (2011) L Ferdinande et al. BRITISH JOURNAL OF CANCER
- Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients
- (2011) Reinhart Speeckaert et al. EUROPEAN JOURNAL OF CANCER
- IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
- (2009) B. Baban et al. JOURNAL OF IMMUNOLOGY
- The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
- (2009) Yan-Fang Gao et al. Journal of Translational Medicine
- Overexpression of Indoleamine 2,3-Dioxygenase in Human Endometrial Carcinoma Cells Induces Rapid Tumor Growth in a Mouse Xenograft Model
- (2008) N. Yoshida et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now